Publications directory

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm

The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.

Results: 246

Cover image of 'EOX chemotherapy [Thai]'

EOX chemotherapy [Thai] (2018)

Macmillan Cancer Support

EOX chemotherapy is used to treat oesophageal cancer and stomach cancer. This factsheet describes the drugs used (epirubicin, oxaliplatin and capecitabine), how the treatment is given and the possible side-effects.

Cover image of 'GemCis chemotherapy [Russian]'

GemCis chemotherapy [Russian] (June 2018)

Macmillan Cancer Support

This is a translation of information from the Macmillan Cancer Support website. It describes the GemCis chemotherapy regimen to treat many cancers, the drugs, how treatment is given, and possible side-effects.

Cover image of 'GemCis chemotherapy [Turkish]'

GemCis chemotherapy [Turkish] (June 2018)

Macmillan Cancer Support

This is a translation of information from the Macmillan Cancer Support website. It describes the GemCis chemotherapy regimen to treat many cancers, the drugs, how treatment is given, and possible side-effects.

Cover image of 'GemCis chemotherapy [Polish]'

GemCis chemotherapy [Polish] (June 2018)

Macmillan Cancer Support

This is a translation of information from the Macmillan Cancer Support website. It describes the GemCis chemotherapy regimen to treat many cancers, the drugs, how treatment is given, and possible side-effects.

Cover image of 'ABVD [Bulgarian]'

ABVD [Bulgarian] (May 2018)

Macmillan Cancer Support

Information from the Macmillan Cancer Support website translated into Bulgarian. ABVD chemotherapy is a combination treatment used to treat Hodgkin Lymphoma. This factsheet describes what it is, how it is given, and possible side effects.

Cover image of 'DA (Daunarubicin) and ARAc for acute myeloid leukaemia. A guide for patients'

DA (Daunarubicin) and ARAc for acute myeloid leukaemia. A guide for patients (December 2018)

Leukaemia Care

This booklet describes DA treatment, a combination of the drugs daunorubicin and cytarabine (Ara-C), used primarily as induction chemotherapy in patients with newly diagnosed acute myeloid meukaemia. It describes how DA is given, and the possible side-effects. Includes a glossary and details of further support and information.

Cover image of 'Future treatments in acute myeloid leukaemia (AML). A guide for patients'

Future treatments in acute myeloid leukaemia (AML). A guide for patients (October 2018)

Leukaemia Care

The main treatment for acute myeloid leukaemia (AML) is chemotherapy, including targeted therapy. This might be followed by a stem cell transplant, and surgery and radiotherapy may be used in special circumstances. New therapies are being developed and investigated and this booklet describes several of these: clofarabine (DNA synthesis inhibitor); gilteritinib and quizartinib (tyrosine kinase inhibitors); venetoclax (B-cell lymphoma-2 (BCL2) inhibitor); and Vyxeos® (a combination of daunorubicin and cytarabine. 

Cover image of 'FEC chemotherapy [Arabic]'

FEC chemotherapy [Arabic] (2017)

Macmillan Cancer Support

FEC is a combination chemotherapy treatment for breast cancer. This factsheet describes the drugs, how they are given and some of the possible side-effects.

Cover image of 'FEC chemotherapy [Portuguese]'

FEC chemotherapy [Portuguese] (September 2017)

Macmillan Cancer Support

FEC is a combination chemotherapy treatment for breast cancer. This factsheet describes the drugs, how they are given and some of the possible side-effects.

Cover image of 'FEC-T chemotherapy [Polish]'

FEC-T chemotherapy [Polish] (2017)

Macmillan Cancer Support

This information describes the FEC-T chemotherapy regimen, which is used to treat breast cancer. It describes the drugs used, how treatment is given, and some of the possible side-effects.

Sorry, no publications found.
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm